Publications by authors named "Martino Introna"

Claim this Profile
A
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches.
Amit Sharma, Dario Sangiolo, Antonio Rosato, Jingjing Pu, Jian Hou, Martino Introna

Cancer Immunol Immunother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody.
Silvia Zaninelli, Irene Cattaneo, Rut Valgardsdottir, Roberta Frapolli, Ezia Bello, Martino Introna

Cancer Immunol Immunother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability.
Ilaria Pisani, Giusi Melita, Patricia Borges de Souza, Stefania Galimberti, Angela Maria Savino, Martino Introna

J Transl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.
Federico Lussana, Chiara F Magnani, Stefania Galimberti, Giuseppe Gritti, Giuseppe Gaipa, Martino Introna

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically modified and unmodified cellular approaches to enhance graft versus leukemia effect, without increasing graft versus host disease: the use of allogeneic cytokine-induced killer cells.
Benedetta Rambaldi, Giuliana Rizzuto, Alessandro Rambaldi, Martino Introna

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab.
Silvia Zaninelli, Silvia Panna, Sarah Tettamanti, Giusi Melita, Andrea Doni, Martino Introna

Antibodies (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL.
Giuseppe Gritti, Silvia Ferrari, Federico Lussana, Anna Maria Barbui, Francesco Landi, Martino Introna

Blood Cancer J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.
Silvia Zaninelli, Cristian Meli, Gianmaria Borleri, Michele Quaroni, Chiara Pavoni, Martino Introna

Cytometry A· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).
Norberto Perico, Giuseppe Remuzzi, Matthew D Griffin, Paul Cockwell, Alexander P Maxwell, Martino Introna

J Am Soc Nephrol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome.
Marina Vivarelli, Manuela Colucci, Mattia Algeri, Federica Zotta, Francesco Emma, Martino Introna

JCI Insight· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potency assays and biomarkers for cell-based advanced therapy medicinal products.
Chiara Capelli, Carolina Cuofano, Chiara Pavoni, Simona Frigerio, Daniela Lisini, Martino Introna

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies.
Chiara Capelli, Simona Frigerio, Daniela Lisini, Sara Nava, Giuseppe Gaipa, Martino Introna

Cytotherapy· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives.
Elisa Agostinetto, Filippo Montemurro, Fabio Puglisi, Carmen Criscitiello, Giampaolo Bianchini, Martino Introna

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use.
Elisa Gotti, Sarah Tettamanti, Silvia Zaninelli, Carolina Cuofano, Irene Cattaneo, Martino Introna

Cytotherapy· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective Effects of Human Nonrenal and Renal Stromal Cells and Their Conditioned Media in a Rat Model of Chronic Kidney Disease.
Barbara Imberti, Domenico Cerullo, Daniela Corna, Cinzia Rota, Monica Locatelli, Martino Introna

Cell Transplant· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third-party bone marrow-derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial.
Federica Casiraghi, Norberto Perico, Manuel A Podestà, Marta Todeschini, Marco Zambelli, Martino Introna

Am J Transplant· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
Martino Introna, Josée Golay

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.
Chiara F Magnani, Giuseppe Gaipa, Federico Lussana, Daniela Belotti, Giuseppe Gritti, Martino Introna

J Clin Invest· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System.
Maria Caterina Rotiroti, Chiara Buracchi, Silvia Arcangeli, Stefania Galimberti, Maria Grazia Valsecchi, Martino Introna

Mol Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration.
Federica Casiraghi, Norberto Perico, Eliana Gotti, Marta Todeschini, Marilena Mister, Martino Introna

Stem Cells Transl Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin.
Fiorenza Orlando, Chiara Paolini, Silvia Agarbati, Cecilia Tonnini, Antonella Grieco, Martino Introna

J Vis Exp· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation.
Josée Golay, Rut Valgardsdottir, Gerta Musaraj, Damiano Giupponi, Orietta Spinelli, Martino Introna

Blood· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.
Cristina Trento, Maria Ester Bernardo, Arnon Nagler, Selim Kuçi, Martin Bornhäuser, Martino Introna

Biol Blood Marrow Transplant· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19 tumors.
Josée Golay, Simona Martinelli, Rachele Alzani, Sabrina Cribioli, Clara Albanese, Martino Introna

Cytotherapy· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.
Cinzia Rota, Marina Morigi, Domenico Cerullo, Martino Introna, Ornella Colpani

Stem Cell Res Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis